Excelsior Orthopaedics LLP
Excelsior Orthopaedics LLP was paid $6.57M by Medicaid between Jan 2018 and Nov 2024, across 55 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 36% of everything it billed.
33Billing provider infoEXCELSIOR ORTHOPAEDICS LLP
AMHERST, NY 14226
AMHERST, NY 14226
33aNPI1831196757assigned 07/07/2005
33bProvider typeSpecialist
28Total paid$6.57M
24GClaims125,146
24DCodes billed55
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Specialist providers in New York
Rank by total paid#25 of 1,221
Median peer was paid$45K
This provider vs. median145×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 6,193 | $314K | |
| 2019 | 11,419 | $570K | |
| 2020 | 12,513 | $606K | |
| 2021 | 18,144 | $939K | |
| 2022 | 19,678 | $1.05M | |
| 2023 | 35,101 | $1.86M | |
| 2024incomplete | 22,098 | $1.23M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 36% | 41,131 | 39,401 | $2.37M |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 14% | 10,942 | 10,938 | $894K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 12% | 21,301 | 7,954 | $784K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 9.6% | 7,246 | 7,089 | $633K |
| G9001 | Coordinated care fee, initial rate | 5.2% | 1,733 | 1,730 | $340K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 4.3% | 2,269 | 2,268 | $279K |
| 20610 | 3.4% | 4,584 | 4,244 | $223K | |
| 73630 | 2.6% | 6,646 | 5,576 | $172K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 2.3% | 7,436 | 2,804 | $150K |
| 20611 | 1.9% | 1,912 | 1,598 | $123K | |
| L3908 | Wrist hand orthosis, wrist extension control cock-up, non molded, prefabricated, off-the-shelf | 1.8% | 2,037 | 1,824 | $116K |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | 1.4% | 361 | 350 | $90K |
43 more codes
| 76942 | <1% | 853 | $63K | |
| 73564 | <1% | 1,665 | $57K | |
| 97164 | <1% | 1,431 | $47K | |
| 73562 | <1% | 992 | $30K | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 5,137 | $28K |
| 73110 | <1% | 750 | $22K | |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | <1% | 1,382 | $19K |
| 73610 | <1% | 732 | $18K | |
| 97161 | <1% | 274 | $17K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 377 | $14K |
| L1902 | Ankle orthosis, ankle gauntlet or similar, with or without joints, prefabricated, off-the-shelf | <1% | 171 | $11K |
| 97803 | <1% | 253 | $9K | |
| 76882 | <1% | 390 | $7K | |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 30 | $7K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 132 | $6K |
| 72110 | <1% | 98 | $4K | |
| 73221 | <1% | 13 | $3K | |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 450 | $3K |
| 73140 | <1% | 112 | $3K | |
| 73030 | <1% | 114 | $3K | |
| 73502 | <1% | 76 | $3K | |
| 76881 | <1% | 42 | $3K | |
| L3040 | Foot, arch support, removable, premolded, longitudinal, each | <1% | 69 | $2K |
| 72141 | <1% | 12 | $2K | |
| 95886 | <1% | 26 | $2K | |
| 97165 | <1% | 37 | $2K | |
| G0127 | Trimming of dystrophic nails, any number | <1% | 173 | $2K |
| 73010 | <1% | 85 | $2K | |
| L1812 | Knee orthosis, elastic with joints, prefabricated, off-the-shelf | <1% | 13 | $962.75 |
| 20550 | <1% | 29 | $941.47 | |
| 73130 | <1% | 30 | $917.32 | |
| 11056 | <1% | 24 | $869.69 | |
| 97168 | <1% | 22 | $775.84 | |
| 72040 | <1% | 16 | $456.70 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,168 | $428.36 |
| 99442 | <1% | 13 | $410.70 | |
| 73080 | <1% | 16 | $405.20 | |
| 11720 | <1% | 12 | $260.64 | |
| 11721 | <1% | 12 | $255.27 | |
| A9579 | Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml | <1% | 124 | $200.81 |
| Q4010 | Cast supplies, short arm cast, adult (11 years +), fiberglass | <1% | 13 | $157.04 |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | <1% | 164 | $124.10 |
| J1010 | Injection, methylprednisolone acetate, 1 mg | <1% | 16 | $109.90 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialLASKI, LISA (EXCECUTIVE ASSISTANT)